Kessler Investment Group, LLC Celcuity Inc. Transaction History

Kessler Investment Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$15.74 - $23.65 $93,275 - $140,149	-5,926 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$19.88 - $25.0 $21,689 - $27,275	-1,091 Reduced 15.55%	5,926 $148,000
Q1 2019 Apr 16, 2019	BUY	$18.38 - $24.44 $40,840 - $54,305	2,222 Added 46.34%	7,017 $154,000
Q4 2018 Jan 11, 2019	BUY	$20.87 - $29.05 $100,071 - $139,294	4,795 New	4,795 $115,000

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kessler Investment Group, LLC with notifications on news.